GRI Stock Analysis: Buy, Sell, or Hold?
GRI - GRI Bio, Inc. Common Stock
$3.26
-0.06 (-1.81%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 13, 2026
Get Alerted When GRI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called GRI this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: GRI is 29.4% above fair value ($2.52). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: GRI is 29.4% above fair value ($2.52). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: GRI is currently trading at $3.26, which is considered extended relative to its 30-day fair value range of $-0.67 to $2.52.
Technical Outlook: Technically, GRI is in a downtrend. Immediate support is located at $0.18, while resistance sits at $6.70.
Market Sentiment: GRI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.50 (+577.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GRI is in a downtrend. Immediate support is located at $0.18, while resistance sits at $6.70.
Market Sentiment: GRI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.50 (+577.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$-0.67 -
$2.52
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding GRI? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+29.4% above fair value)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 577.7% below Wall St target ($22.50)
- WARNING: Recommendation downgraded due to 29.4% overvaluation
Fair Price Analysis
30-Day Fair Range
$-0.67 -
$2.52
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.18
Resistance Level
$6.70
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.64
Wall Street Target
$22.50
(+577.7%)
Last updated: January 31, 2026 12:59 PM ET
Data refreshes hourly during market hours. Next update: 1:59 PM
Data refreshes hourly during market hours. Next update: 1:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRI showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced GRI Option Strategies
Professional options setups generated by AI based on today's GRI price and gamma walls.
